Literature DB >> 16258845

Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in oligodendrocyte cell line (OLN-93).

Katarzyna Wejksza1, Wojciech Rzeski, Etsuo Okuno, Martyna Kandefer-Szerszen, Jan Albrecht, Waldemar A Turski.   

Abstract

In the present study we demonstrate for the first time that both kynurenine aminotransferase (KAT) isoforms I and II are present in the permanent immature rat oligodendrocytes cell line (OLN-93). Moreover, we provide evidence that OLN-93 cells are able to synthesize kynurenic acid (KYNA) from exogenously added L-kynurenine and we characterize its regulation by extrinsic factors. KYNA production in OLN-93 cells was depressed in the presence of aminotransferase inhibitor, aminooxyacetic acid and was not affected by depolarizing agents such as 50 mM K+ and 4-aminopyridine. Glutamate agonists, L-glutamate and D,L-homocysteine significantly decreased KYNA production. Selective agonist of ionotropic glutamate receptors Amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropionic acid (AMPA) lowered KYNA production in OLN-93 cell line, whereas N-methyl-D-aspartate (NMDA) had no influence on KYNA production. Furthermore, KYNA synthesis in OLN-93 cells was decreased in a concentration-dependent manner by amino acids transported by L-system, L-leucine, L-cysteine and L-tryptophan. The role of KYNA synthesis in oligodendrocytes needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258845     DOI: 10.1007/s11064-005-6178-z

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  Release of proinflammatory cytokines by mitogen-stimulated peripheral blood mononuclear cells from critically ill multiple-trauma victims.

Authors:  L M Shahbazian; M Jeevanandam; S R Petersen
Journal:  Metabolism       Date:  1999-11       Impact factor: 8.694

Review 2.  Biology of oligodendrocyte and myelin in the mammalian central nervous system.

Authors:  N Baumann; D Pham-Dinh
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

3.  An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid.

Authors:  M N Perkins; T W Stone
Journal:  Brain Res       Date:  1982-09-09       Impact factor: 3.252

4.  Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons.

Authors:  Wojciech Rzeski; Tomasz Kocki; Anna Dybel; Katarzyna Wejksza; Barbara Zdzisińska; Martyna Kandefer-Szerszeń; Waldemar A Turski; Etsuo Okuno; Jan Albrecht
Journal:  J Neurosci Res       Date:  2005-06-01       Impact factor: 4.164

5.  The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.

Authors:  C Hilmas; E F Pereira; M Alkondon; A Rassoulpour; R Schwarcz; E X Albuquerque
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

6.  Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.

Authors:  E Luchowska; P Luchowski; R Paczek; A Ziembowicz; T Kocki; W A Turski; M Wielosz; J Lazarewicz; E M Urbanska
Journal:  J Neurosci Res       Date:  2005-02-01       Impact factor: 4.164

7.  Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor.

Authors:  P J Birch; C J Grossman; A G Hayes
Journal:  Eur J Pharmacol       Date:  1988-09-01       Impact factor: 4.432

8.  Impairment of brain kynurenic acid production by glutamate metabotropic receptor agonists.

Authors:  E M Urbanska; T Kocki; T Saran; Z Kleinrok; W A Turski
Journal:  Neuroreport       Date:  1997-11-10       Impact factor: 1.837

Review 9.  Oligodendroglia in developmental neurotoxicity.

Authors:  Wenbin Deng; Ronald D Poretz
Journal:  Neurotoxicology       Date:  2003-03       Impact factor: 4.294

10.  Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine.

Authors:  W A Turski; J B Gramsbergen; H Traitler; R Schwarcz
Journal:  J Neurochem       Date:  1989-05       Impact factor: 5.372

View more
  13 in total

1.  Quantitative Analysis of Kynurenine Aminotransferase II in the Adult Rat Brain Reveals High Expression in Proliferative Zones and Corpus Callosum.

Authors:  Chang Song; Sarah M Clark; Chloe N Vaughn; James D Nicholson; Kelley J Murphy; Ta-Chung M Mou; Robert Schwarcz; Gloria E Hoffman; Leonardo H Tonelli
Journal:  Neuroscience       Date:  2017-11-08       Impact factor: 3.590

2.  New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio.

Authors:  Tomasz Kocki; Sebastian Wnuk; Renata Kloc; Janusz Kocki; Björn Owe-Larsson; Ewa M Urbanska
Journal:  J Neural Transm (Vienna)       Date:  2011-06-10       Impact factor: 3.575

Review 3.  Cystathionine-β-Synthase: Molecular Regulation and Pharmacological Inhibition.

Authors:  Karim Zuhra; Fiona Augsburger; Tomas Majtan; Csaba Szabo
Journal:  Biomolecules       Date:  2020-04-30

Review 4.  Behavioral experiences as drivers of oligodendrocyte lineage dynamics and myelin plasticity.

Authors:  Lyl Tomlinson; Cindy V Leiton; Holly Colognato
Journal:  Neuropharmacology       Date:  2015-09-28       Impact factor: 5.250

5.  Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression.

Authors:  Ebrahim Haroon; James R Welle; Bobbi J Woolwine; David R Goldsmith; Wendy Baer; Trusharth Patel; Jennifer C Felger; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2020-01-15       Impact factor: 7.853

Review 6.  Kynurenine pathway metabolites and suicidality.

Authors:  Elena Y Bryleva; Lena Brundin
Journal:  Neuropharmacology       Date:  2016-01-26       Impact factor: 5.250

7.  Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder.

Authors:  Nicholas W S Davies; Gilles Guillemin; Bruce J Brew
Journal:  Int J Tryptophan Res       Date:  2010-06-10

8.  Understanding the roles of the kynurenine pathway in multiple sclerosis progression.

Authors:  Chai K Lim; Bruce J Brew; Gayathri Sundaram; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2010-08-25

9.  Protective Effects of Berberine on Oxygen-Glucose Deprivation/Reperfusion on Oligodendrocyte Cell Line (OLN-93).

Authors:  Shabnam Nadjafi; Soltan-Ahmad Ebrahimi; Nahid Rahbar-Roshandel
Journal:  Int J Prev Med       Date:  2014-09

10.  Involvement of the kynurenine pathway in human glioma pathophysiology.

Authors:  Seray Adams; Charles Teo; Kerrie L McDonald; Anna Zinger; Sonia Bustamante; Chai K Lim; Gayathri Sundaram; Nady Braidy; Bruce J Brew; Gilles J Guillemin
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.